MedPath

Efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C

Not Applicable
Recruiting
Conditions
Patients with chronic hepatitis C virus infection
Registration Number
JPRN-UMIN000025050
Lead Sponsor
Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

1) Contraindication to elbasvir or grazoprevir 2) Contraindication to elbasvir and grazoprevir

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath